Proposed score for survival of patients with myelodysplastic syndromes.
|
Sep 2013
|
Eur J Clin Invest
|
myelodysplastic syndromes (MDS)
|
The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.
|
Sep 2013
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
|
Sep 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
Management of the refractory aplastic anemia patient: what are the options?
|
Sep 2013
|
Blood
|
aplastic anemia
|
Hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes.
|
Oct 2013
|
J Natl Compr Canc Netw
|
myelodysplastic syndromes (MDS)
|
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.
|
Oct 2013
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?
|
Oct 2013
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.
|
Oct 2013
|
Am J Hematol
|
aplastic anemia
|
Myelodysplastic syndromes: toward a risk-adapted treatment approach.
|
Oct 2013
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
Should elderly patients with higher-risk myelodysplastic syndromes undergo allogeneic hematopoietic stem cell transplantation?
|
Oct 2013
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|